Analysis Life Sciences Thank You What We Expect the FDA to do in December 2023
Agency IQ
DECEMBER 1, 2023
12/29/2023 FDORA, Section 3602 Clinical Trials Modernization : FDA is directed to require the submission of a “diversity action plan” for all Phase 3 clinical trials of new drugs. ” These include the use of expansion cohorts, concurrent trial conduct, and other designs. .” to include devices.
40 
Let's personalize your content